Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
High Sensitive ELISA Kit for Thymic Stromal Lymphopoietin (TSLP)
- Product No.HEB320Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range7.8-500pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 3.1pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 350
For more details, please contact local distributors! US$ 500 US$ 2250 US$ 4250 US$ 35000
Specificity
This assay has high sensitivity and excellent specificity for detection of High Sensitive Thymic Stromal Lymphopoietin (TSLP).
No significant cross-reactivity or interference between High Sensitive Thymic Stromal Lymphopoietin (TSLP) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant High Sensitive Thymic Stromal Lymphopoietin (TSLP) and the recovery rates were calculated by comparing the measured value to the expected amount of High Sensitive Thymic Stromal Lymphopoietin (TSLP) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 79-98 | 87 |
EDTA plasma(n=5) | 84-98 | 89 |
heparin plasma(n=5) | 88-104 | 97 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level High Sensitive Thymic Stromal Lymphopoietin (TSLP) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level High Sensitive Thymic Stromal Lymphopoietin (TSLP) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of High Sensitive Thymic Stromal Lymphopoietin (TSLP) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 87-102% | 93-101% | 78-91% | 81-105% |
EDTA plasma(n=5) | 81-99% | 95-102% | 81-93% | 86-95% |
heparin plasma(n=5) | 93-102% | 97-105% | 78-91% | 88-102% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Journal of Interferon & Cytokine Research | Epithelial Cell-Derived Cytokines Contribute to the Pathophysiology of Eosinophilic Chronic Rhinosinusitis Pubmed:26540312 |
Allergology International | The effect of calprotectin on TSLP and IL-25 production from airway epithelial cells pubmed:27475624 |
International Journal of Molecular Sciences | Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice Pubmed: 30544712 |
Dermatol Reports | Skin tissue expression and serum level of thymic stromal lymphopoietin in patients with psoriasis vulgaris Pubmed: 31316739 |